AQUA
Get informed when a big investor buys or sells
+ FollowUndervalued by 2.4% based on the discounted cash flow analysis.
| Market cap | $6.10 Billion |
|---|---|
| Enterprise Value | $7.02 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.6 |
| Beta | 1.79 |
| Outstanding Shares | 125,795,000 |
| P/E Ratio | 83.69 |
|---|---|
| PEG | 185.78 |
| Price to Sales | 3.56 |
| Price to Book Ratio | 9.98 |
| Enterprise Value to Revenue | 3.78 |
| Enterprise Value to EBIT | 60.11 |
| Enterprise Value to Net Income | 89 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 1.4 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
This committee provides the official revenue estimates and technical analysis for all tax legislation. Its influence on the structure and scoring of tax bills directly impacts corporate tax burdens, capital investment incentives, and overall fiscal policy that affects AQUA's profitability.
As the primary tax-writing committee, it dictates corporate tax policy, trade regulations, and healthcare spending. Changes in corporate tax rates or trade tariffs could significantly impact AQUA's profitability, investment decisions, and global supply chain costs.
This committee directly allocates discretionary federal spending. Its subcommittees determine precise funding for various government programs, including clean water infrastructure projects (e.g., State Revolving Funds), EPA, and DoD, which are key customers or market drivers for AQUA.
This committee directly regulates the EPA and is central to federal infrastructure programs. AQUA's business, which focuses on water and wastewater treatment, is profoundly affected by EPA regulations, water quality standards, and 'infrastructure super-cycle' funding for water systems.